Search

You searched for "funding"

2509 results found

Interacoustics introduces a new diagnostic test at EUHA

3 October 2023 | Research & Development
Interacoustics is happy to introduce the Audible Contrast Threshold (ACT™) test; a new, diagnostic test to support the number one challenge with hearing loss: difficulty hearing speech in background noise.

VACANCY: Audiology Partner – Bexleyheath

4 October 2023 | Recruitment & Personnel
Grow your own business, look after your private and NHS customers, serve your community, create an asset for your family’s future and enjoy the profits of all your hard work.

UV Smart D60: sustainability in every disinfection cycle

31 October 2023 | Company Profiles
The UV Smart D60 is a CE marked (MDR Class IIa) disinfection device specifically designed for channel-less ENT endoscopes and TEE probes.

Puma S.r.l. at 69th EUHA International Congress

6 November 2025 | Company Profiles, Awards, Conferences & Anniversaries
The 69th EUHA International Congress took place in Nuremberg from 22 to 24 October, bringing together leading experts in the field of audiology. Puma S.r.l. actively participated with its own stand, where it presented, as a preview, the new PRO28F...

Cochlear implant care: putting patients in charge

1 September 2017 | | ENTA - Audiology - Adult, ENTA - Audiology - Diagnostic, ENTA - Audiology - Auditory Implants, ENTA - Otology
Should patients take charge of their own cochlear implant care? Helen Cullington presents a compelling case that will provoke discussion in implant centres. Around 1400 people receive a cochlear implant in the UK each year. Patients require lifetime annual follow-up...

Embracing the changes prompted by lockdown

2 November 2020 | | ENTA - Audiology - Adult, ENTA - Audiology - Diagnostic
March 2020 introduced the concept of lockdown to audiology services in the NHS, prompting a rethink of how to best provide hearing care. In this issue, we hear from Hanna Jeffery, a Clinical Scientist working at the Royal Glamorgan Hospital...

Audiological testing strategies for children and young people with ASD

3 May 2022 | | ENTA - Audiology - Paediatric
In 2014 the Hummingbird Clinic was opened, offering a bespoke clinic for children with complex needs or autism. In this article Keiran Joseph shares the wealth of knowledge gained in this clinic over the years and offers some top tips...

The changing landscape for hearing loss therapeutics: novel advances of gene and cell therapies

3 September 2024 | | ENTA - Audiology - Adult
Recent years have seen advances in hearing loss therapeutics, with novel treatments trialled in humans, and others nearing promising first-in-kind clinical trials. First successful clinical trials for a specific form of genetic hearing loss Very exciting news has emerged in...

Otology training in low- and middle-income countries: a view from within

5 July 2022 | | ENTA - Otology
It is recognised that hearing loss and ear disease are far more common in less affluent parts of the world, and that those countries are often least able to provide treatment; so how can we prioritise care for these patients?...

From the editor JulAug19

1 July 2019 |
Declan Costello, MA, MBBS, FRCS(ORL-HNS), Editor, ENT & Audiology News; Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.net Welcome We are delighted to launch this current edition of ENT & Audiology News from Brussels,...

AAA 2025 + Hear TECH Expo

26 March 2025 -29 March 2025 | ENTA - Audiology - Adult, ENTA - Audiology - Diagnostic, ENTA - Audiology - Paediatric, ENTA - Audiology - Auditory Implants
Lilian Felipe, Associate Chair for the Doctor of Audiology Program, Lamar University, USABringing together over 3,000 professionals in hearing and balance healthcare, the highly anticipated annual conference from the American Academy of Audiology (AAA) served as a dynamic hub for...

COOL therapy for cisplatin-induced hearing loss

5 July 2022 | | ENTA - Audiology - Adult, ENTA - Audiology - Paediatric
Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...